Modified directly observed therapy to improve HIV treatment outcomes: Little impact with potent, once-daily therapy in unselected antiretroviral- naïve patients

Current HIV/AIDS Reports

Volumn 6, Issue 4, 2009, Pages 173-174

  Bangsberg, David R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Harvard Initiative for Global Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EMTRICITABINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE; TENOFOVIR;

CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; DRUG POTENCY; DRUG SUBSTITUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; NOTE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENINE; ANTI-HIV AGENTS; DEOXYCYTIDINE; DIRECTLY OBSERVED THERAPY; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; MEDICATION ADHERENCE; PHOSPHONIC ACIDS; PYRIMIDINONES; RITONAVIR; SELF ADMINISTRATION; STAVUDINE; TREATMENT OUTCOME;

EID: 70350012313     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-009-0031-y     Document Type: Note

References (12)

1. D.R. Bangsberg F.M. Hecht E.D. Charlebois, et al. 2000 Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population AIDS 14 357 366 10.1097/00002030-200003100-00008 1:CAS:528:DC%2BD3cXis1egu7s%3D 10770537 (Pubitemid 30182431)
2. D.L. Paterson S. Swindells J. Mohr, et al. 2000 Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 21 30 1:STN:280:DC%2BD3czit1altA%3D%3D 10877736
3. L.R. Kirkland M.A. Fischl K.T. Tashima, et al. 2002 Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment Clin Infect Dis 34 511 518 10.1086/338400 1:CAS:528:DC%2BD38XhsFSitb4%3D 11797179 (Pubitemid 34112273)
4. F.L. Altice D.S. Maru R.D. Bruce, et al. 2007 Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial Clin Infect Dis 45 770 778 10.1086/521166 1:CAS:528:DC%2BD2sXhtFahtrrF 17712763 (Pubitemid 47378892)
5. G.E. Macalino J.W. Hogan J.A. Mitty, et al. 2007 A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users AIDS 21 1473 1477 10.1097/QAD.0b013e32811ebf68 17589194 (Pubitemid 46988008)
6. D.A. Wohl B.L. Stephenson C.E. Golin, et al. 2003 Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates Clin Infect Dis 36 1572 1576 10.1086/375076 12802758 (Pubitemid 36783342)
7. G.M. Lucas P.J. Weidle S. Hader R.D. Moore 2004 Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study Clin Infect Dis 38Suppl5 S409 S413 10.1086/421405 (Pubitemid 38738539)
8. R.H. Remien M.J. Stirratt C. Dolezal, et al. 2005 Couple-focused support to improve HIV medication adherence: a randomized controlled trial AIDS 19 807 814 10.1097/01.aids.0000168975.44219.45 15867495
9. K.R. Amico J.J. Harman B.T. Johnson 2006 Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004 J Acquir Immune Defic Syndr 41 285 297 10.1097/01.qai.0000197870.99196.ea 16540929
10. J.M. Molina T.J. Podsadecki M.A. Johnson, et al. 2007 A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks AIDS Res Hum Retroviruses 23 1505 1514 10.1089/aid.2007.0107 1:CAS:528:DC%2BD1cXhtVKqug%3D%3D 18160008
11. D.R. Bangsberg 2006 Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression Clin Infect Dis 43 939 941 10.1086/507526 1:CAS:528:DC%2BD28XhtVKhsrbP 16941380 (Pubitemid 44435526)
12. J. Shuter J.A. Sarlo T.J. Kanmaz, et al. 2007 HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95% J Acquir Immune Defic Syndr 45 4 8 10.1097/QAI.0b013e318050d8c2 1:CAS:528:DC%2BD2sXksFOltro%3D 17460469 (Pubitemid 46684437)